Analysis Of Income And Expense [Abstract]

GENFLOW BIOSCIENCES PLC - Filing #1906463

Concept 2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2021-01-18 to
2021-12-31
2021-01-18 to
2021-12-31
2021-01-18 to
2021-12-31
2021-01-18 to
2021-12-31
2021-01-18 to
2021-12-31
2021-01-18 to
2021-12-31
Analysis of income and expense [abstract]
Material income and expense [abstract]
Impairment loss (reversal of impairment loss) on trade receivables [abstract]
Impairment loss recognised in profit or loss, trade receivables
- GBP
50,000 GBP
Other operating income (expense)
487,293 GBP
- GBP
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income
- GBP
1,260,163 GBP
75,158 GBP
1,260,167 GBP
- GBP
1,335,325 GBP
- GBP
1,002,260 GBP
14,065 GBP
1,002,260 GBP
- GBP
988,195 GBP
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent
1,260,167 GBP
1,002,260 GBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.